Güzide Yücebilgiç

Dr. Güzide Yücebilgiç


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
NGNuri Gulesci
Nuri Gulesci
GYGüzide Yücebilgiç
Güzide Yücebilgiç
DYDeniz Yildirim
Deniz Yildirim
Objectives: This study aims the covalent immobilization of Jack bean urease on Fe 3 O 4 magnetic nanoparticles via glutaraldehyde (urease@MNPs-Si-Glu) and epichlorohydrin (urease@MNPs-ECH) spacer arms. Methods: The optimum pH and temperature, thermal, storage and reuse stability of free and immobilized urease preparations were investigated. Thermodynamics characterizations of free and immobilized urease preparations were also studied. Results: The free urease and both immobilized urease preparations showed maximal catalytic activity at pH 7.5. The free urease had a maximal catalytic activity at 50 °C, while the both immobilized urease preparations exhibited their maximal catalytic activities at 70 °C. The urease@MNPs-Si-Glu and urease@MNP-ECH showed 2.7- and 1.9-fold higher thermal stability than the free urease at 60 °C, respectively. The free urease remained 30% of their initial activity at 4 °C, while urease@MNPs-Si-Glu and urease@MNPs-ECH retained 72 and 60% of their initial activities at the same conditions. The urease@MNPs-Si-Glu and urease@MNPs-ECH preserved 53 and 52% of their initial activities, respectively for urea hydrolysis after 20 reuses. Conclusions: The urease@MNPs-Si-Glu and urease@MNPs-ECH may find a potential application area in urea hydrolysis.

27 November 2025 in Molecules
Verified
Journal Article
Open access
PDF file
FVFirst3509 Varan
First3509 Varan
ATAli Toprak
Ali Toprak
GYGüzide Yücebilgiç
Güzide Yücebilgiç
DADilek Alagöz
Dilek Alagöz
DYDeniz Yildirim
Deniz Yildirim
Roberto Fernandez-LafuenteRoberto Fernandez-Lafuente
Roberto Fernandez-Lafuente
This study reports the immobilization of β-mannanase from Aspergillus niger—either unmodified or genipin-modified—within polyvinyl alcohol hydrogels (PVA@mannanase and PVA@mannanase-Gen) for the enhanced production of mannooligosaccharides (MOSs). All enzyme preparations showed an optimal pH of 5.0, while immobilization shifted the optimal temperature from 40 °C for the free enzyme to 55 °C for the immobilized forms. Genipin modification notably improved stability, increasing the half-life from 25.3 h (free enzyme) to 429.2 h in PVA@mannanase-Gen, and raised catalytic efficiency by approximately 2.3-fold. Both immobilized preparations retained over 75% of their activity after five reuse cycles at pH 5 and 55 °C. Using PVA@mannanase-Gen under these optimized conditions, MOSs were effectively produced, with mannotetraose as the predominant product. To explore their potential applications, the MOSs generated from locust bean gum were evaluated for effects on MCF-7 and HCT-116 cancer cell lines, resulting in moderate growth inhibition (~24–25% at 0.4 mM after 24 h). Together, these findings demonstrate that the immobilization of the genipin-modified enzyme not only enhances β-mannanase stability and performance but also supports the efficient production of MOSs with promising antitumoral activity.

20 March 2022 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
EÇErcan ÇINAR
Ercan ÇINAR
EAErsin Akgöllü
Ersin Akgöllü
GYGüzide Yücebilgiç
Güzide Yücebilgiç
RBRamazan Bilgin
Ramazan Bilgin
SPSemra Paydas
Semra Paydas
Non-Hodgkin Lymphoma (NHL) is a malignant lymphoproliferative disease. Antioxidant paraoxonase enzyme (PON1) has a vital role in the elimination of potential carcinogenic organophosphate molecules. The polymorphisms in the PON1 gene, especially Q192R and L55M, may affect negatively the activity and synthesis of PON1 enzyme. The aim of this study was to evaluate the effect of these polymorphisms together with PON1 enzyme activity on NHL. We surveyed these polymorphisms together with PON1 enzyme activity in 93 patients with NHL and in 93 healthy individuals by real-time polymerase chain reaction (RT-PCR) and spectrophotometer. Although carrying the M and R alleles of L55M and Q192R polymorphisms increases the risk of NHL, they were not significant. Furthermore, the NHL patients carrying 192 R allele had significantly lower enzyme activity than controls having same allele (P = 0.025). This research is the first study worldwide investigating the effect of Q192R and L55M polymorphisms on PON1 enzyme activity in NHL disease. The risk of developing NHL may be further increased in individuals with low enzyme activity having R risk allele of the Q192R polymorphism. The present study suggests that these polymorphisms in NHL disease should be analyzed together with PON1 enzyme activity in larger populations. Supplemental data for this article is available online at https://doi.org/10.1080/15257770.2022.2052315 .